1022953-36-1

Basic information

• Product Name: 5-hydroxy-1-(phenylsulfonyl)-1H-indole-4-carbaldehyde
• Synonyms: 5-hydroxy-1-(phenylsulfonyl)-1H-indole-4-carbaldehyde
• CAS NO: 1022953-36-1
• Molecular Weight: 301.323
• Mol File: 1022953-36-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-hydroxy-1-(phenylsulfonyl)-1H-indole-4-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5-hydroxy-1-(phenylsulfonyl)-1H-indole-4-carbaldehyde(1022953-36-1)
• EPA Substance Registry System: 5-hydroxy-1-(phenylsulfonyl)-1H-indole-4-carbaldehyde(1022953-36-1)

Safety Data

• Hazardous Substances Data: 1022953-36-1(Hazardous Substances Data)

Upstream product

• 170147-24-7 5-(benzyloxy)-1-(phenylsulfonyl)-1H-indole 
• 98-09-9 benzenesulfonyl chloride 
• 146073-34-9 1-phenylsulfonyl-5-hydroxy-1H-indole 
• 1215-59-4 5-benzyloxy-1H-indole 
• 1022953-33-8 4-(hydroxymethyl)-1-(phenylsulfonyl)-1H-indol-5-ol 

Downstream Products

• 1022953-46-3 (7aS)-3-(phenylsuIfonyl)-3,7a,8,9,10,12-hexahydro-7H-pyrrolo [2',1':3,4][1,4]oxazepino[6,7-e]indole 
• 1022953-39-4 (7aR)-3-(phenylsuIfonyl)-3,7a,8,9,10,12-hexahydro-7H-pyrrolo [2',1':3,4][1,4]oxazepino[6,7-e]indole 
• 1022953-56-5 (3S)-2,3-dimethyl-8-(phenylsulfonyI)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022954-79-5 (3R)-2,3-dimethyl-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022953-50-9 (3S)-3-methyl-8-(phenylsulfonyI)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022954-75-1 (3R)-3-methyl-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022954-68-2 tert-butyl ((1R)-2-{[4-formyl-1-(phenylsulfonyl)-1H-indol-5-yl]oxy}-1-methylethyl)carbamate 

Relevant articles and documents

8-SULFONYL-L, 3, 4, 8-TETRAHYDR0-2H- [1, 4] OXAZEPINO [6, 7-E] INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS

The present invention relates to compounds of the formula (I) wherein A, X and R1 to R9 are as described herein; to pharmaceutical compositions comprising the said compounds; to processes for their preparation; and to the use of the compounds as medicaments against 5-HT6 receptor-related disorders.